VIENNA – The immune checkpoint inhibitor nivolumab extended overall survival by 5.4 months compared with standard therapy in patients with advanced kidney cancer in the phase III CheckMate 025...
SAN FRANCISCO – Many younger women diagnosed with triple-negative breast cancers do not get tested for BRCA, despite guideline recommendations, investigators report.
Among 173 women with...
SAN FRANCISCO – Many younger women diagnosed with triple-negative breast cancers do not get tested for BRCA, despite guideline recommendations, investigators report.
Among 173 women with...
SAN FRANCISCO – MRI-screening may improve the detection of biologically relevant breast cancer in women who are at average-risk, and reduce the interval-cancer rate down to 0%, at a low...
SAN FRANCISCO – MRI-screening may improve the detection of biologically relevant breast cancer in women who are at average-risk, and reduce the interval-cancer rate down to 0%, at a low...
SAN FRANCISCO – The use of aromatase inhibitors (AIs) in the adjuvant setting appears to delay the development of contralateral breast cancer, and this effect was particularly prevalent among breast...
SAN FRANCISCO – The use of aromatase inhibitors (AIs) in the adjuvant setting appears to delay the development of contralateral breast cancer, and this effect was particularly prevalent among breast...
New recommendations for the treatment of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis largely echo each other in many respective clinical circumstances that are...